PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
33849997-5	2021	Metformin has beneficial effects in humans in tissues with high levels of mGPD such as pancreatic beta cells where mGPD is much higher than in liver.	Metformin	0-9	atypical chemokine receptor 1 (Duffy blood group)	Mus musculus	74-78	
33849997-5	2021	Metformin has beneficial effects in humans in tissues with high levels of mGPD such as pancreatic beta cells where mGPD is much higher than in liver.	Metformin	0-9	atypical chemokine receptor 1 (Duffy blood group)	Mus musculus	115-119	
33849997-7	2021	For these and other reasons we used four different enzyme assays to reassess whether metformin inhibited mGPD.	Metformin	85-94	atypical chemokine receptor 1 (Duffy blood group)	Mus musculus	105-109	
33849997-9	2021	If metformin actually inhibited mGPD, adverse effects in tissues where the level of mGPD is much higher than in liver could prevent metformin"s use as a diabetes medicine.	Metformin	3-12	atypical chemokine receptor 1 (Duffy blood group)	Mus musculus	32-36	
33849997-9	2021	If metformin actually inhibited mGPD, adverse effects in tissues where the level of mGPD is much higher than in liver could prevent metformin"s use as a diabetes medicine.	Metformin	3-12	atypical chemokine receptor 1 (Duffy blood group)	Mus musculus	84-88	
33849997-9	2021	If metformin actually inhibited mGPD, adverse effects in tissues where the level of mGPD is much higher than in liver could prevent metformin"s use as a diabetes medicine.	Metformin	132-141	atypical chemokine receptor 1 (Duffy blood group)	Mus musculus	32-36	
33849997-9	2021	If metformin actually inhibited mGPD, adverse effects in tissues where the level of mGPD is much higher than in liver could prevent metformin"s use as a diabetes medicine.	Metformin	132-141	atypical chemokine receptor 1 (Duffy blood group)	Mus musculus	84-88	
25808533-3	2015	The reduction of gluconeogenesis evoked by metformin may be a result of an energy deficit evoked through the inhibition of mitochondrial respiratory chain complex I and/or increased cytosolic redox state and decreased mitochondrial redox state elicited by the inhibition of mitochondrial glycerophosphate dehydrogenase (mGPD).	Metformin	43-52	atypical chemokine receptor 1 (Duffy blood group)	Mus musculus	320-324	
25808533-5	2015	Recently, it was reported that inhibition of mGPD by metformin decreases the level of dihydroxyacetone phosphate and reduces the conversion of lactate to pyruvate, that in consequence diminishes the utilization of glycerol and lactate for gluconeogenesis.	Metformin	53-62	atypical chemokine receptor 1 (Duffy blood group)	Mus musculus	45-49